New Update
In a major development, the Drugs Controller General of India (DCGI) on Wednesday gave a nod for conducting a study on mixing Covid-19 vaccines 'Covaxin and Covishield'.
During a press briefing on Tuesday, Dr. VK Paul, Niti Aayog, had said that permission has been granted for a research study by CMC Vellore (Tamil Nadu) on mixing of Covid-19 vaccines doses — Covaxin and Covishield.
Tokyo Olympics 2020: List of medal winners, historic golden throw by Neeraj Chopra, India’s record-breaking journey
Earlier, the Indian Council of Medical Research (ICMR) had revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the Covid-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogenicity results.
Also Read | Tokyo Olympics 2020: Meet unsung heroes behind the success of India’s medal winners
The nationwide vaccination program had entered into 4th month when the event of mixed dosing raised considerable anxiety in the public domain with the potential to contributing to vaccine hesitancy.
ICMR conducted the current investigation against that backdrop. In the study, ICMR compared the safety and immunogenicity profile with those individuals who received either Covaxin or Covishield and it showed better results.
The study conducted on individuals in the northern state of Uttar Pradesh in India received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks.
-PTC News-
Also Read |